Evidence map›Paper›PMID 36875300›Full record

ArticleCancer diagnosis & prognosis

Clinical Outcomes of Stereotactic Body Radiation Therapy for Early-stage Non-small Cell Lung Cancer.

Yutaro Tasaki, Kazuto Ashizawa, Daisuke Nakamura, Takashi Mizowaki, Seiji Nagashima, Toshifumi Fujimoto, Masataka Uetani

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer diagnosis & prognosis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Yutaro TasakiDepartment of Radiology, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan.
Kazuto AshizawaClinical Oncology Center, Nagasaki University Hospital, Nagasaki, Japan.
Daisuke NakamuraDepartment of Radiology, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan.
Takashi MizowakiDepartment of Radiology, Sasebo City General Hospital, Nagasaki, Japan.
Seiji NagashimaDepartment of Respiratory Medicine, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan.
Toshifumi FujimotoDepartment of Radiology, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan.
Masataka UetaniDepartment of Radiological Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Nagasaki Medical Center · JPNagasaki University · JPNagasaki University Hospital · JPSasebo City General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimTo investigate the clinical outcomes of stereotactic body radiotherapy (SBRT) in patients with early-stage non-small cell lung cancer (NSCLC). PATIENTS AND

methodsAmong consecutive patients with early-stage NSCLC who received SBRT between November 2009 and September 2019, those with cT1-2N0M0 staged by the UICC TNM classification and staging system for lung cancer were retrospectively analyzed.

resultsFifty-three patients with early-stage NSCLC received SBRT. The median follow-up period was 29 months (range=2-105 months). Twenty-one lung tumors were clinically diagnosed as early-stage primary lung cancers without histological confirmation. Histological examinations revealed adenocarcinoma in 24 patients and squamous cell carcinoma in 8. Two- and 5-year local control, cancer-specific survival, progression-free survival (PFS), and overall survival (OS) rates were 94.4 and 94.4%; 94.6 and 90.8%; 69.0 and 43.3%; and 80.0 and 59.3%, respectively. In a univariate analysis, the T stage, histology, and type of pulmonary nodule correlated with PFS and OS.

conclusionGood clinical outcomes were achieved by patients with early-stage NSCLC who received SBRT.

Indexed as

non-small cell lung cancerradiotherapyStereotactic body radiotherapy

Identifiers

PMID36875300
PMCPMC9949538
OpenAlexW4323295132

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.